Prevelance of Klebsiella Pneumonie in the Respiratory ICU
ConditionKlebsiella Pneumoniae
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University
About this trial
This observational study aims to determine the prevalence of Klebsiella pneumoniae isolates among respiratory specimens collected from adult patients admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, and to describe their antimicrobial resistance profiles and associated clinical and epidemiological characteristics
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
Adult patients aged 18 years or older admitted to the Respiratory Intensive Care Unit at Sohag University Hospital, with Klebsiella pneumoniae isolated from respiratory specimens.
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
No intervention (observational study)
Other interventionno intervention
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
prevelance of klebsiella pneumoniae isolates
prevalence/isolation rate of klebsiella pneumoniae among respiratory specimens collected from adult patients admitted to the respiratory intensive care at sohag university hospital
Time frame
from june 2026 to june 2027Secondary outcomes
1
Antimicrobial Resistance profile of klebsiella pneumoniae isolates
Antimicrobial susceptibility patterns of Klebsiella pneumoniae isolates will be assessed separately for each tested antimicrobial agent based on antimicrobial susceptibility testing results.
Time frame
from June 2026 to June 20272
Clinical and Epidemiological characteristics of patients with klebsiella pneumoniae isolation
Clinical and epidemiological characteristics including age, underlying illness, mechanical ventilation, and duration of intensive care unit stay.
Time frame
from June 2026 to June 2027Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov